Chemotherapy

Alkylating agents - ICD Code - Y43.3

Bendamustine Hydrochloride

This medication is an alkylating agent, prescribed for chronic lymphocytic leukemia (CLL), and non-Hodgkin lymphoma (NHL).

Carmustine

This medication is an anti-cancer drug, prescribed for certain types of cancers like multiple myeloma, brain tumor, Hodgkin’s and non – Hodgkin’s lymphoma.

Mechlorethamine

This medication is an alkylating agent, prescribed for certain types of cancer.

Antimetabolites - ICD Code - Y43.1

Azacitidine

This medication is an antineoplastic agent, prescribed for blood cancer.

Antimetabolites - ICD Code - Y43.3

Cladribine

This medication is a synthetic anti-cancer agent, prescribed for hairy cell leukemia.

Clofarabine

This medication is a form of antimetabolite chemotherapy, prescribed for leukemia in children and adolescents.

Decitabine

This medication is a nucleoside analog, prescribed for myelodysplastic syndromes (MDS).

Antitumor Antibiotics - ICD Code - Y43.3

Aclarubicin

Aclarubicin or aclacinomycin A is used to treat acute non lymphocytic leukemia, a cancer of the blood and bone marrow.

Hormonal Therapy - ICD Code - Y43.3

Abarelix

Abarelix is used to treat prostate cancer for reducing the symptoms and to increase the quality of life in patients.

Abiraterone acetate is used along with prednisolone (corticosteroid) for treating a type of prostate cancer called metastatic castration-resistant prostate cancer (mCRPC) previously called hormone-resistant cancer.

Buserelin

This medication is a gonadotropin-releasing hormone agonist, prescribed for prostate cancer and breast cancer.

Diethylstilbestrol

This medication is a synthetic nonsteroidal estrogen, prescribed for the prevention of miscarriage, breast cancer, premature birth and prostate enlargement.

Miscellaneous Antineoplastics - ICD Code - Y43.3

Aldesleukin

Aldesleukin is a cancer-treating drug prescribed for treating advanced kidney cancer or renal cell carcinoma and metastatic skin cancer that has spread to other parts of the body.

Bexarotene

This medication is an oral antineoplastic agent, prescribed for cutaneous T-cell lymphoma (CTCL, a type of skin cancer), lung cancer, breast cancer and Kaposi's sarcoma.

Brentuximab Vedotin

This medication is a monoclonal antibody, prescribed for certain types of lymphoma (Hodgkin lymphoma, systemic anaplastic large cell lymphoma [sALCL]).

Cabazitaxel

This medication is an antineoplastic agent, prescribed for prostate cancer with prednisone.

Denileukin Diftitox

This medication is an anticancer agent, prescribed for lymphoma.

Eribulin Mesylate

This medication is an anticancer agent, prescribed for breast cancer.

Exemestane

This medication is an aromatase inhibitor, prescribed for advanced breast cancer in postmenopausal women who are no longer responsive to anti-estrogen therapy.

Gefitinib

This medication is a chemotherapy agent, prescribed for non-small cell lung cancer.

Interferon Alfa 2A

This medication is prescribed for hairy cell leukemia (blood cancer), AIDS-related Kaposi's sarcoma (type of cancer that develops in connective tissues), recurrent or metastatic renal cell carcinoma (kidney cancer) and chronic myelogenous leukemia (cancer of white blood cells), hepatitis C, non-Hodgin’s lymphoma.

Interferon Alfa-N3 -Human Leukocyte Derived

This medication is a protein, prescribed for genital warts caused by human papilloma virus (HPV).

Interferon Beta 1A

This medication is an immunomodulator, prescribed for multiple sclerosis.

Interferon Gamma 1B

This medication is a protein, prescribed for reducing the repeated occurrences and severity of serious infections associated with chronic granulomatous disease.

Ixabepilone

This medication is prescribed for breast cancer either alone or in combination with capecitabine.

Lapatinib

This medication is a protein-tyrosine kinase inhibitor, prescribed for metastatic breast cancer with other medications.

Letrozole

This medication is an aromatase inhibitor, prescribed for breast cancer either alone or in combination with other medications.

Monoclonal antibody - ICD Code - Y43.3

Alemtuzumab

Alemtuzumab is a cancer-treating drug used for treating certain cancers of bone marrow and blood cancers such as chronic lymphocytic leukemia (CLL) and lymphoma.

Bevacizumab

This medication is used to treat certain types of advanced lung cancer.

Gemtuzumab

This medication is an anti-cancer agent, prescribed for certain type of leukemia in people who are at least 60 years old.

Ibritumomab Tiuxetan

This medication is a monoclonal antibody, prescribed for non-Hodgkin's lymphoma with other medications.

Proteasome Inhibitor - ICD Code - Y43.3

Bortezomib

This medication is an antineoplastic agent, prescribed for multiple myeloma and mantle cell lymphoma.

Tryosine Kinase Inhibitor - ICD Code - Y43.3

Axitinib Tablets

This medication is a kinase inhibitor, prescribed for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy.

Dasatinib

This medication is prescribed for blood cancer(Chronic Myeloid Leukemia).

Imatinib

This medication is a protein-tyrosine kinase inhibitor, prescribed for treating certain type of cancers such as chronic myelogenous leukemia (cancer of the white blood cells, acute lymphoblastic leukemia(cancer of the white blood cells), gastrointestinal stromal tumors (tumors of the gastrointestinal tract and other cancers.